nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—UGT1A1—lung cancer	0.27	0.658	CbGaD
Flurbiprofen—PTGS2—lung cancer	0.0744	0.181	CbGaD
Flurbiprofen—ALB—lung cancer	0.0663	0.161	CbGaD
Flurbiprofen—UGT1A9—Irinotecan—lung cancer	0.0439	0.134	CbGbCtD
Flurbiprofen—UGT1A1—Erlotinib—lung cancer	0.0397	0.121	CbGbCtD
Flurbiprofen—UGT1A1—Irinotecan—lung cancer	0.0359	0.11	CbGbCtD
Flurbiprofen—UGT1A1—Etoposide—lung cancer	0.0287	0.0878	CbGbCtD
Flurbiprofen—ALB—Gefitinib—lung cancer	0.0255	0.0778	CbGbCtD
Flurbiprofen—ABCC4—Methotrexate—lung cancer	0.0194	0.0593	CbGbCtD
Flurbiprofen—PTGS2—Cisplatin—lung cancer	0.0176	0.0537	CbGbCtD
Flurbiprofen—PTGS2—Etoposide—lung cancer	0.0173	0.0528	CbGbCtD
Flurbiprofen—ALB—Erlotinib—lung cancer	0.0151	0.046	CbGbCtD
Flurbiprofen—PTGS1—Etoposide—lung cancer	0.0146	0.0446	CbGbCtD
Flurbiprofen—CYP2C9—Gefitinib—lung cancer	0.0137	0.0419	CbGbCtD
Flurbiprofen—ALB—Irinotecan—lung cancer	0.0136	0.0416	CbGbCtD
Flurbiprofen—CYP2C9—Teniposide—lung cancer	0.0133	0.0407	CbGbCtD
Flurbiprofen—UGT2B4—pericardium—lung cancer	0.0115	0.544	CbGeAlD
Flurbiprofen—SLC22A6—Methotrexate—lung cancer	0.00845	0.0258	CbGbCtD
Flurbiprofen—CYP2C9—Paclitaxel—lung cancer	0.00743	0.0227	CbGbCtD
Flurbiprofen—ALB—Methotrexate—lung cancer	0.0072	0.022	CbGbCtD
Flurbiprofen—CYP2C9—Cisplatin—lung cancer	0.00598	0.0183	CbGbCtD
Flurbiprofen—UGT2B4—cardiac atrium—lung cancer	0.00152	0.072	CbGeAlD
Flurbiprofen—UGT2B4—lung—lung cancer	0.00116	0.055	CbGeAlD
Flurbiprofen—ALB—mammary gland—lung cancer	0.00103	0.049	CbGeAlD
Flurbiprofen—Mefenamic acid—AKR1C1—lung cancer	0.000745	0.201	CrCbGaD
Flurbiprofen—CYP2C9—mammary gland—lung cancer	0.000645	0.0306	CbGeAlD
Flurbiprofen—ABCC4—bronchus—lung cancer	0.000549	0.026	CbGeAlD
Flurbiprofen—PTGS1—respiratory system—lung cancer	0.000393	0.0186	CbGeAlD
Flurbiprofen—ABCC4—bone marrow—lung cancer	0.000391	0.0185	CbGeAlD
Flurbiprofen—PTGS2—respiratory system—lung cancer	0.000375	0.0178	CbGeAlD
Flurbiprofen—ABCC4—lung—lung cancer	0.000354	0.0168	CbGeAlD
Flurbiprofen—Suprofen—UGT1A1—lung cancer	0.000345	0.0932	CrCbGaD
Flurbiprofen—PTGS1—epithelium—lung cancer	0.000328	0.0156	CbGeAlD
Flurbiprofen—PTGS2—epithelium—lung cancer	0.000314	0.0149	CbGeAlD
Flurbiprofen—PTGS2—bronchus—lung cancer	0.000309	0.0147	CbGeAlD
Flurbiprofen—PTGS1—trachea—lung cancer	0.00029	0.0138	CbGeAlD
Flurbiprofen—PTGS2—trachea—lung cancer	0.000277	0.0132	CbGeAlD
Flurbiprofen—PTGS1—cardiac atrium—lung cancer	0.000273	0.0129	CbGeAlD
Flurbiprofen—Naproxen—UGT1A1—lung cancer	0.000271	0.0731	CrCbGaD
Flurbiprofen—ALB—lymph node—lung cancer	0.00025	0.0119	CbGeAlD
Flurbiprofen—ABCC4—lymph node—lung cancer	0.000242	0.0115	CbGeAlD
Flurbiprofen—PTGS2—bone marrow—lung cancer	0.00022	0.0104	CbGeAlD
Flurbiprofen—PTGS1—lung—lung cancer	0.000209	0.00989	CbGeAlD
Flurbiprofen—PTGS2—lung—lung cancer	0.000199	0.00945	CbGeAlD
Flurbiprofen—Ibuprofen—UGT1A1—lung cancer	0.000173	0.0467	CrCbGaD
Flurbiprofen—Ketoprofen—CXCL8—lung cancer	0.000166	0.0447	CrCbGaD
Flurbiprofen—Ibuprofen—CXCL8—lung cancer	0.000163	0.044	CrCbGaD
Flurbiprofen—Carprofen—PTGS2—lung cancer	0.000154	0.0415	CrCbGaD
Flurbiprofen—PTGS1—lymph node—lung cancer	0.000143	0.00676	CbGeAlD
Flurbiprofen—PTGS2—lymph node—lung cancer	0.000136	0.00646	CbGeAlD
Flurbiprofen—Tiaprofenic acid—PTGS2—lung cancer	0.000125	0.0338	CrCbGaD
Flurbiprofen—Fenbufen—PTGS2—lung cancer	0.000114	0.0308	CrCbGaD
Flurbiprofen—Diflunisal—PTGS2—lung cancer	0.00011	0.0296	CrCbGaD
Flurbiprofen—Warfarin—CYP1A1—lung cancer	0.0001	0.027	CrCbGaD
Flurbiprofen—Oxaprozin—PTGS2—lung cancer	9.9e-05	0.0267	CrCbGaD
Flurbiprofen—Salsalate—PTGS2—lung cancer	9.9e-05	0.0267	CrCbGaD
Flurbiprofen—Diflunisal—ALB—lung cancer	9.76e-05	0.0263	CrCbGaD
Flurbiprofen—Suprofen—PTGS2—lung cancer	9.5e-05	0.0256	CrCbGaD
Flurbiprofen—Fenoprofen—PTGS2—lung cancer	8.18e-05	0.0221	CrCbGaD
Flurbiprofen—Mefenamic acid—PTGS2—lung cancer	7.59e-05	0.0205	CrCbGaD
Flurbiprofen—Naproxen—PTGS2—lung cancer	7.45e-05	0.0201	CrCbGaD
Flurbiprofen—Fenoprofen—ALB—lung cancer	7.29e-05	0.0197	CrCbGaD
Flurbiprofen—Nitrazepam—CYP2E1—lung cancer	6.69e-05	0.0181	CrCbGaD
Flurbiprofen—Naproxen—ALB—lung cancer	6.64e-05	0.0179	CrCbGaD
Flurbiprofen—Warfarin—ALB—lung cancer	5.58e-05	0.0151	CrCbGaD
Flurbiprofen—Eosinophilia—Doxorubicin—lung cancer	4.94e-05	0.000357	CcSEcCtD
Flurbiprofen—Sweating—Methotrexate—lung cancer	4.93e-05	0.000355	CcSEcCtD
Flurbiprofen—Palpitations—Docetaxel—lung cancer	4.93e-05	0.000355	CcSEcCtD
Flurbiprofen—Feeling abnormal—Cisplatin—lung cancer	4.92e-05	0.000355	CcSEcCtD
Flurbiprofen—Paraesthesia—Etoposide—lung cancer	4.92e-05	0.000355	CcSEcCtD
Flurbiprofen—Haematuria—Methotrexate—lung cancer	4.9e-05	0.000354	CcSEcCtD
Flurbiprofen—Loss of consciousness—Docetaxel—lung cancer	4.9e-05	0.000353	CcSEcCtD
Flurbiprofen—Pancreatitis—Doxorubicin—lung cancer	4.9e-05	0.000353	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Paclitaxel—lung cancer	4.89e-05	0.000353	CcSEcCtD
Flurbiprofen—Dyspnoea—Etoposide—lung cancer	4.88e-05	0.000352	CcSEcCtD
Flurbiprofen—Somnolence—Etoposide—lung cancer	4.87e-05	0.000351	CcSEcCtD
Flurbiprofen—Cough—Docetaxel—lung cancer	4.86e-05	0.000351	CcSEcCtD
Flurbiprofen—Angina pectoris—Doxorubicin—lung cancer	4.86e-05	0.000351	CcSEcCtD
Flurbiprofen—Insomnia—Paclitaxel—lung cancer	4.85e-05	0.00035	CcSEcCtD
Flurbiprofen—Epistaxis—Methotrexate—lung cancer	4.85e-05	0.00035	CcSEcCtD
Flurbiprofen—Hypersensitivity—Irinotecan—lung cancer	4.85e-05	0.00035	CcSEcCtD
Flurbiprofen—Ketoprofen—PTGS2—lung cancer	4.83e-05	0.013	CrCbGaD
Flurbiprofen—Convulsion—Docetaxel—lung cancer	4.83e-05	0.000348	CcSEcCtD
Flurbiprofen—Paraesthesia—Paclitaxel—lung cancer	4.82e-05	0.000348	CcSEcCtD
Flurbiprofen—Hypertension—Docetaxel—lung cancer	4.81e-05	0.000347	CcSEcCtD
Flurbiprofen—Bronchitis—Doxorubicin—lung cancer	4.8e-05	0.000346	CcSEcCtD
Flurbiprofen—Agranulocytosis—Methotrexate—lung cancer	4.8e-05	0.000346	CcSEcCtD
Flurbiprofen—Dyspnoea—Paclitaxel—lung cancer	4.79e-05	0.000345	CcSEcCtD
Flurbiprofen—Somnolence—Paclitaxel—lung cancer	4.77e-05	0.000344	CcSEcCtD
Flurbiprofen—Decreased appetite—Etoposide—lung cancer	4.76e-05	0.000343	CcSEcCtD
Flurbiprofen—Ibuprofen—PTGS2—lung cancer	4.76e-05	0.0128	CrCbGaD
Flurbiprofen—Myalgia—Docetaxel—lung cancer	4.75e-05	0.000342	CcSEcCtD
Flurbiprofen—Pancytopenia—Doxorubicin—lung cancer	4.74e-05	0.000342	CcSEcCtD
Flurbiprofen—Nausea—Vinorelbine—lung cancer	4.74e-05	0.000342	CcSEcCtD
Flurbiprofen—Dyspepsia—Paclitaxel—lung cancer	4.72e-05	0.000341	CcSEcCtD
Flurbiprofen—Body temperature increased—Cisplatin—lung cancer	4.72e-05	0.000341	CcSEcCtD
Flurbiprofen—Diazepam—CYP2E1—lung cancer	4.72e-05	0.0127	CrCbGaD
Flurbiprofen—Asthenia—Irinotecan—lung cancer	4.72e-05	0.000341	CcSEcCtD
Flurbiprofen—Pain—Etoposide—lung cancer	4.68e-05	0.000338	CcSEcCtD
Flurbiprofen—Constipation—Etoposide—lung cancer	4.68e-05	0.000338	CcSEcCtD
Flurbiprofen—Neutropenia—Doxorubicin—lung cancer	4.67e-05	0.000337	CcSEcCtD
Flurbiprofen—Dysuria—Doxorubicin—lung cancer	4.67e-05	0.000337	CcSEcCtD
Flurbiprofen—Decreased appetite—Paclitaxel—lung cancer	4.67e-05	0.000337	CcSEcCtD
Flurbiprofen—Dry mouth—Docetaxel—lung cancer	4.64e-05	0.000335	CcSEcCtD
Flurbiprofen—Haemoglobin—Methotrexate—lung cancer	4.64e-05	0.000335	CcSEcCtD
Flurbiprofen—Haemorrhage—Methotrexate—lung cancer	4.62e-05	0.000333	CcSEcCtD
Flurbiprofen—Hepatitis—Methotrexate—lung cancer	4.62e-05	0.000333	CcSEcCtD
Flurbiprofen—Asthenia—Gemcitabine—lung cancer	4.6e-05	0.000332	CcSEcCtD
Flurbiprofen—Pain—Paclitaxel—lung cancer	4.59e-05	0.000331	CcSEcCtD
Flurbiprofen—Constipation—Paclitaxel—lung cancer	4.59e-05	0.000331	CcSEcCtD
Flurbiprofen—Confusional state—Docetaxel—lung cancer	4.59e-05	0.000331	CcSEcCtD
Flurbiprofen—Pharyngitis—Methotrexate—lung cancer	4.58e-05	0.00033	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Doxorubicin—lung cancer	4.56e-05	0.000329	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Docetaxel—lung cancer	4.55e-05	0.000328	CcSEcCtD
Flurbiprofen—Oedema—Docetaxel—lung cancer	4.55e-05	0.000328	CcSEcCtD
Flurbiprofen—Pruritus—Gemcitabine—lung cancer	4.54e-05	0.000327	CcSEcCtD
Flurbiprofen—Infection—Docetaxel—lung cancer	4.52e-05	0.000326	CcSEcCtD
Flurbiprofen—Feeling abnormal—Etoposide—lung cancer	4.51e-05	0.000325	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Doxorubicin—lung cancer	4.5e-05	0.000325	CcSEcCtD
Flurbiprofen—Diarrhoea—Irinotecan—lung cancer	4.5e-05	0.000325	CcSEcCtD
Flurbiprofen—Pneumonia—Doxorubicin—lung cancer	4.48e-05	0.000323	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Etoposide—lung cancer	4.48e-05	0.000323	CcSEcCtD
Flurbiprofen—Shock—Docetaxel—lung cancer	4.48e-05	0.000323	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Docetaxel—lung cancer	4.45e-05	0.000321	CcSEcCtD
Flurbiprofen—Drowsiness—Doxorubicin—lung cancer	4.45e-05	0.000321	CcSEcCtD
Flurbiprofen—Visual impairment—Methotrexate—lung cancer	4.45e-05	0.000321	CcSEcCtD
Flurbiprofen—Tachycardia—Docetaxel—lung cancer	4.44e-05	0.00032	CcSEcCtD
Flurbiprofen—Feeling abnormal—Paclitaxel—lung cancer	4.42e-05	0.000319	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Doxorubicin—lung cancer	4.41e-05	0.000318	CcSEcCtD
Flurbiprofen—Hypersensitivity—Cisplatin—lung cancer	4.4e-05	0.000318	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Paclitaxel—lung cancer	4.39e-05	0.000317	CcSEcCtD
Flurbiprofen—Diarrhoea—Gemcitabine—lung cancer	4.39e-05	0.000316	CcSEcCtD
Flurbiprofen—Renal failure—Doxorubicin—lung cancer	4.38e-05	0.000316	CcSEcCtD
Flurbiprofen—Erythema multiforme—Methotrexate—lung cancer	4.36e-05	0.000315	CcSEcCtD
Flurbiprofen—Dizziness—Irinotecan—lung cancer	4.35e-05	0.000314	CcSEcCtD
Flurbiprofen—Urticaria—Etoposide—lung cancer	4.35e-05	0.000314	CcSEcCtD
Flurbiprofen—Stomatitis—Doxorubicin—lung cancer	4.34e-05	0.000313	CcSEcCtD
Flurbiprofen—Jaundice—Doxorubicin—lung cancer	4.34e-05	0.000313	CcSEcCtD
Flurbiprofen—Anorexia—Docetaxel—lung cancer	4.34e-05	0.000313	CcSEcCtD
Flurbiprofen—Body temperature increased—Etoposide—lung cancer	4.33e-05	0.000312	CcSEcCtD
Flurbiprofen—Abdominal pain—Etoposide—lung cancer	4.33e-05	0.000312	CcSEcCtD
Flurbiprofen—Conjunctivitis—Doxorubicin—lung cancer	4.33e-05	0.000312	CcSEcCtD
Flurbiprofen—Urinary tract infection—Doxorubicin—lung cancer	4.33e-05	0.000312	CcSEcCtD
Flurbiprofen—Ketoprofen—ALB—lung cancer	4.3e-05	0.0116	CrCbGaD
Flurbiprofen—Tinnitus—Methotrexate—lung cancer	4.3e-05	0.00031	CcSEcCtD
Flurbiprofen—Asthenia—Cisplatin—lung cancer	4.29e-05	0.000309	CcSEcCtD
Flurbiprofen—Sweating—Doxorubicin—lung cancer	4.27e-05	0.000308	CcSEcCtD
Flurbiprofen—Urticaria—Paclitaxel—lung cancer	4.26e-05	0.000308	CcSEcCtD
Flurbiprofen—Hypotension—Docetaxel—lung cancer	4.25e-05	0.000307	CcSEcCtD
Flurbiprofen—Haematuria—Doxorubicin—lung cancer	4.24e-05	0.000306	CcSEcCtD
Flurbiprofen—Abdominal pain—Paclitaxel—lung cancer	4.24e-05	0.000306	CcSEcCtD
Flurbiprofen—Body temperature increased—Paclitaxel—lung cancer	4.24e-05	0.000306	CcSEcCtD
Flurbiprofen—Ibuprofen—ALB—lung cancer	4.24e-05	0.0114	CrCbGaD
Flurbiprofen—Epistaxis—Doxorubicin—lung cancer	4.2e-05	0.000303	CcSEcCtD
Flurbiprofen—Angiopathy—Methotrexate—lung cancer	4.19e-05	0.000302	CcSEcCtD
Flurbiprofen—Vomiting—Irinotecan—lung cancer	4.18e-05	0.000302	CcSEcCtD
Flurbiprofen—Sinusitis—Doxorubicin—lung cancer	4.18e-05	0.000301	CcSEcCtD
Flurbiprofen—Agranulocytosis—Doxorubicin—lung cancer	4.15e-05	0.0003	CcSEcCtD
Flurbiprofen—Rash—Irinotecan—lung cancer	4.15e-05	0.000299	CcSEcCtD
Flurbiprofen—Dermatitis—Irinotecan—lung cancer	4.15e-05	0.000299	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Docetaxel—lung cancer	4.14e-05	0.000299	CcSEcCtD
Flurbiprofen—Chills—Methotrexate—lung cancer	4.14e-05	0.000299	CcSEcCtD
Flurbiprofen—Headache—Irinotecan—lung cancer	4.12e-05	0.000297	CcSEcCtD
Flurbiprofen—Insomnia—Docetaxel—lung cancer	4.11e-05	0.000297	CcSEcCtD
Flurbiprofen—Diarrhoea—Cisplatin—lung cancer	4.09e-05	0.000295	CcSEcCtD
Flurbiprofen—Paraesthesia—Docetaxel—lung cancer	4.09e-05	0.000295	CcSEcCtD
Flurbiprofen—Alopecia—Methotrexate—lung cancer	4.08e-05	0.000294	CcSEcCtD
Flurbiprofen—Vomiting—Gemcitabine—lung cancer	4.08e-05	0.000294	CcSEcCtD
Flurbiprofen—Dyspnoea—Docetaxel—lung cancer	4.06e-05	0.000293	CcSEcCtD
Flurbiprofen—Somnolence—Docetaxel—lung cancer	4.04e-05	0.000292	CcSEcCtD
Flurbiprofen—Ibuprofen—ABCB1—lung cancer	4.04e-05	0.0109	CrCbGaD
Flurbiprofen—Rash—Gemcitabine—lung cancer	4.04e-05	0.000292	CcSEcCtD
Flurbiprofen—Dermatitis—Gemcitabine—lung cancer	4.04e-05	0.000291	CcSEcCtD
Flurbiprofen—Hypersensitivity—Etoposide—lung cancer	4.03e-05	0.000291	CcSEcCtD
Flurbiprofen—Haemoglobin—Doxorubicin—lung cancer	4.02e-05	0.00029	CcSEcCtD
Flurbiprofen—Headache—Gemcitabine—lung cancer	4.02e-05	0.00029	CcSEcCtD
Flurbiprofen—Rhinitis—Doxorubicin—lung cancer	4.01e-05	0.000289	CcSEcCtD
Flurbiprofen—Dyspepsia—Docetaxel—lung cancer	4e-05	0.000289	CcSEcCtD
Flurbiprofen—Hepatitis—Doxorubicin—lung cancer	4e-05	0.000288	CcSEcCtD
Flurbiprofen—Haemorrhage—Doxorubicin—lung cancer	4e-05	0.000288	CcSEcCtD
Flurbiprofen—Pharyngitis—Doxorubicin—lung cancer	3.97e-05	0.000286	CcSEcCtD
Flurbiprofen—Decreased appetite—Docetaxel—lung cancer	3.95e-05	0.000285	CcSEcCtD
Flurbiprofen—Hypersensitivity—Paclitaxel—lung cancer	3.95e-05	0.000285	CcSEcCtD
Flurbiprofen—Asthenia—Etoposide—lung cancer	3.93e-05	0.000283	CcSEcCtD
Flurbiprofen—Nausea—Irinotecan—lung cancer	3.91e-05	0.000282	CcSEcCtD
Flurbiprofen—Constipation—Docetaxel—lung cancer	3.89e-05	0.000281	CcSEcCtD
Flurbiprofen—Pain—Docetaxel—lung cancer	3.89e-05	0.000281	CcSEcCtD
Flurbiprofen—Pruritus—Etoposide—lung cancer	3.87e-05	0.000279	CcSEcCtD
Flurbiprofen—Visual impairment—Doxorubicin—lung cancer	3.85e-05	0.000278	CcSEcCtD
Flurbiprofen—Asthenia—Paclitaxel—lung cancer	3.85e-05	0.000278	CcSEcCtD
Flurbiprofen—Nausea—Gemcitabine—lung cancer	3.81e-05	0.000275	CcSEcCtD
Flurbiprofen—Vomiting—Cisplatin—lung cancer	3.8e-05	0.000274	CcSEcCtD
Flurbiprofen—Pruritus—Paclitaxel—lung cancer	3.8e-05	0.000274	CcSEcCtD
Flurbiprofen—Erythema multiforme—Doxorubicin—lung cancer	3.78e-05	0.000273	CcSEcCtD
Flurbiprofen—Rash—Cisplatin—lung cancer	3.77e-05	0.000272	CcSEcCtD
Flurbiprofen—Dermatitis—Cisplatin—lung cancer	3.76e-05	0.000271	CcSEcCtD
Flurbiprofen—Feeling abnormal—Docetaxel—lung cancer	3.75e-05	0.00027	CcSEcCtD
Flurbiprofen—Diarrhoea—Etoposide—lung cancer	3.75e-05	0.00027	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Methotrexate—lung cancer	3.73e-05	0.000269	CcSEcCtD
Flurbiprofen—Tinnitus—Doxorubicin—lung cancer	3.73e-05	0.000269	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Docetaxel—lung cancer	3.72e-05	0.000268	CcSEcCtD
Flurbiprofen—Anaemia—Methotrexate—lung cancer	3.71e-05	0.000268	CcSEcCtD
Flurbiprofen—Diarrhoea—Paclitaxel—lung cancer	3.67e-05	0.000265	CcSEcCtD
Flurbiprofen—Angiopathy—Doxorubicin—lung cancer	3.63e-05	0.000262	CcSEcCtD
Flurbiprofen—Malaise—Methotrexate—lung cancer	3.62e-05	0.000261	CcSEcCtD
Flurbiprofen—Dizziness—Etoposide—lung cancer	3.62e-05	0.000261	CcSEcCtD
Flurbiprofen—Vertigo—Methotrexate—lung cancer	3.61e-05	0.00026	CcSEcCtD
Flurbiprofen—Abdominal pain—Docetaxel—lung cancer	3.6e-05	0.000259	CcSEcCtD
Flurbiprofen—Body temperature increased—Docetaxel—lung cancer	3.6e-05	0.000259	CcSEcCtD
Flurbiprofen—Leukopenia—Methotrexate—lung cancer	3.6e-05	0.000259	CcSEcCtD
Flurbiprofen—Chills—Doxorubicin—lung cancer	3.59e-05	0.000259	CcSEcCtD
Flurbiprofen—Arrhythmia—Doxorubicin—lung cancer	3.57e-05	0.000257	CcSEcCtD
Flurbiprofen—Dizziness—Paclitaxel—lung cancer	3.55e-05	0.000256	CcSEcCtD
Flurbiprofen—Nausea—Cisplatin—lung cancer	3.55e-05	0.000256	CcSEcCtD
Flurbiprofen—Alopecia—Doxorubicin—lung cancer	3.53e-05	0.000255	CcSEcCtD
Flurbiprofen—Cough—Methotrexate—lung cancer	3.51e-05	0.000253	CcSEcCtD
Flurbiprofen—Nitrazepam—ABCB1—lung cancer	3.51e-05	0.00946	CrCbGaD
Flurbiprofen—Convulsion—Methotrexate—lung cancer	3.48e-05	0.000251	CcSEcCtD
Flurbiprofen—Vomiting—Etoposide—lung cancer	3.48e-05	0.000251	CcSEcCtD
Flurbiprofen—Rash—Etoposide—lung cancer	3.45e-05	0.000249	CcSEcCtD
Flurbiprofen—Dermatitis—Etoposide—lung cancer	3.45e-05	0.000249	CcSEcCtD
Flurbiprofen—Headache—Etoposide—lung cancer	3.43e-05	0.000247	CcSEcCtD
Flurbiprofen—Flatulence—Doxorubicin—lung cancer	3.43e-05	0.000247	CcSEcCtD
Flurbiprofen—Myalgia—Methotrexate—lung cancer	3.42e-05	0.000247	CcSEcCtD
Flurbiprofen—Tension—Doxorubicin—lung cancer	3.41e-05	0.000246	CcSEcCtD
Flurbiprofen—Vomiting—Paclitaxel—lung cancer	3.41e-05	0.000246	CcSEcCtD
Flurbiprofen—Rash—Paclitaxel—lung cancer	3.38e-05	0.000244	CcSEcCtD
Flurbiprofen—Dermatitis—Paclitaxel—lung cancer	3.38e-05	0.000244	CcSEcCtD
Flurbiprofen—Discomfort—Methotrexate—lung cancer	3.38e-05	0.000244	CcSEcCtD
Flurbiprofen—Nervousness—Doxorubicin—lung cancer	3.38e-05	0.000244	CcSEcCtD
Flurbiprofen—Headache—Paclitaxel—lung cancer	3.36e-05	0.000243	CcSEcCtD
Flurbiprofen—Hypersensitivity—Docetaxel—lung cancer	3.35e-05	0.000242	CcSEcCtD
Flurbiprofen—Confusional state—Methotrexate—lung cancer	3.31e-05	0.000238	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Methotrexate—lung cancer	3.28e-05	0.000236	CcSEcCtD
Flurbiprofen—Asthenia—Docetaxel—lung cancer	3.26e-05	0.000235	CcSEcCtD
Flurbiprofen—Infection—Methotrexate—lung cancer	3.26e-05	0.000235	CcSEcCtD
Flurbiprofen—Nausea—Etoposide—lung cancer	3.25e-05	0.000235	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Doxorubicin—lung cancer	3.23e-05	0.000233	CcSEcCtD
Flurbiprofen—Pruritus—Docetaxel—lung cancer	3.22e-05	0.000232	CcSEcCtD
Flurbiprofen—Anaemia—Doxorubicin—lung cancer	3.22e-05	0.000232	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Methotrexate—lung cancer	3.21e-05	0.000232	CcSEcCtD
Flurbiprofen—Nausea—Paclitaxel—lung cancer	3.19e-05	0.00023	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Methotrexate—lung cancer	3.17e-05	0.000229	CcSEcCtD
Flurbiprofen—Malaise—Doxorubicin—lung cancer	3.14e-05	0.000226	CcSEcCtD
Flurbiprofen—Vertigo—Doxorubicin—lung cancer	3.13e-05	0.000225	CcSEcCtD
Flurbiprofen—Anorexia—Methotrexate—lung cancer	3.13e-05	0.000225	CcSEcCtD
Flurbiprofen—Syncope—Doxorubicin—lung cancer	3.12e-05	0.000225	CcSEcCtD
Flurbiprofen—Leukopenia—Doxorubicin—lung cancer	3.11e-05	0.000225	CcSEcCtD
Flurbiprofen—Diarrhoea—Docetaxel—lung cancer	3.11e-05	0.000224	CcSEcCtD
Flurbiprofen—Palpitations—Doxorubicin—lung cancer	3.07e-05	0.000222	CcSEcCtD
Flurbiprofen—Hypotension—Methotrexate—lung cancer	3.06e-05	0.000221	CcSEcCtD
Flurbiprofen—Loss of consciousness—Doxorubicin—lung cancer	3.06e-05	0.000221	CcSEcCtD
Flurbiprofen—Cough—Doxorubicin—lung cancer	3.04e-05	0.000219	CcSEcCtD
Flurbiprofen—Convulsion—Doxorubicin—lung cancer	3.01e-05	0.000217	CcSEcCtD
Flurbiprofen—Dizziness—Docetaxel—lung cancer	3.01e-05	0.000217	CcSEcCtD
Flurbiprofen—Hypertension—Doxorubicin—lung cancer	3e-05	0.000217	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Methotrexate—lung cancer	2.99e-05	0.000215	CcSEcCtD
Flurbiprofen—Insomnia—Methotrexate—lung cancer	2.97e-05	0.000214	CcSEcCtD
Flurbiprofen—Myalgia—Doxorubicin—lung cancer	2.96e-05	0.000214	CcSEcCtD
Flurbiprofen—Anxiety—Doxorubicin—lung cancer	2.95e-05	0.000213	CcSEcCtD
Flurbiprofen—Paraesthesia—Methotrexate—lung cancer	2.94e-05	0.000212	CcSEcCtD
Flurbiprofen—Discomfort—Doxorubicin—lung cancer	2.93e-05	0.000211	CcSEcCtD
Flurbiprofen—Dyspnoea—Methotrexate—lung cancer	2.92e-05	0.000211	CcSEcCtD
Flurbiprofen—Somnolence—Methotrexate—lung cancer	2.92e-05	0.00021	CcSEcCtD
Flurbiprofen—Dry mouth—Doxorubicin—lung cancer	2.9e-05	0.000209	CcSEcCtD
Flurbiprofen—Vomiting—Docetaxel—lung cancer	2.89e-05	0.000209	CcSEcCtD
Flurbiprofen—Dyspepsia—Methotrexate—lung cancer	2.89e-05	0.000208	CcSEcCtD
Flurbiprofen—Rash—Docetaxel—lung cancer	2.87e-05	0.000207	CcSEcCtD
Flurbiprofen—Dermatitis—Docetaxel—lung cancer	2.87e-05	0.000207	CcSEcCtD
Flurbiprofen—Confusional state—Doxorubicin—lung cancer	2.86e-05	0.000206	CcSEcCtD
Flurbiprofen—Decreased appetite—Methotrexate—lung cancer	2.85e-05	0.000206	CcSEcCtD
Flurbiprofen—Headache—Docetaxel—lung cancer	2.85e-05	0.000206	CcSEcCtD
Flurbiprofen—Oedema—Doxorubicin—lung cancer	2.84e-05	0.000205	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Doxorubicin—lung cancer	2.84e-05	0.000205	CcSEcCtD
Flurbiprofen—Infection—Doxorubicin—lung cancer	2.82e-05	0.000203	CcSEcCtD
Flurbiprofen—Pain—Methotrexate—lung cancer	2.8e-05	0.000202	CcSEcCtD
Flurbiprofen—Shock—Doxorubicin—lung cancer	2.79e-05	0.000201	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Doxorubicin—lung cancer	2.78e-05	0.0002	CcSEcCtD
Flurbiprofen—Tachycardia—Doxorubicin—lung cancer	2.77e-05	0.0002	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Doxorubicin—lung cancer	2.74e-05	0.000198	CcSEcCtD
Flurbiprofen—Anorexia—Doxorubicin—lung cancer	2.71e-05	0.000195	CcSEcCtD
Flurbiprofen—Nausea—Docetaxel—lung cancer	2.7e-05	0.000195	CcSEcCtD
Flurbiprofen—Feeling abnormal—Methotrexate—lung cancer	2.7e-05	0.000195	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Methotrexate—lung cancer	2.68e-05	0.000193	CcSEcCtD
Flurbiprofen—Hypotension—Doxorubicin—lung cancer	2.65e-05	0.000191	CcSEcCtD
Flurbiprofen—Urticaria—Methotrexate—lung cancer	2.6e-05	0.000188	CcSEcCtD
Flurbiprofen—Diazepam—ALB—lung cancer	2.59e-05	0.007	CrCbGaD
Flurbiprofen—Abdominal pain—Methotrexate—lung cancer	2.59e-05	0.000187	CcSEcCtD
Flurbiprofen—Body temperature increased—Methotrexate—lung cancer	2.59e-05	0.000187	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.59e-05	0.000187	CcSEcCtD
Flurbiprofen—Insomnia—Doxorubicin—lung cancer	2.57e-05	0.000185	CcSEcCtD
Flurbiprofen—Paraesthesia—Doxorubicin—lung cancer	2.55e-05	0.000184	CcSEcCtD
Flurbiprofen—Dyspnoea—Doxorubicin—lung cancer	2.53e-05	0.000183	CcSEcCtD
Flurbiprofen—Somnolence—Doxorubicin—lung cancer	2.52e-05	0.000182	CcSEcCtD
Flurbiprofen—Dyspepsia—Doxorubicin—lung cancer	2.5e-05	0.00018	CcSEcCtD
Flurbiprofen—Diazepam—ABCB1—lung cancer	2.48e-05	0.00668	CrCbGaD
Flurbiprofen—Decreased appetite—Doxorubicin—lung cancer	2.47e-05	0.000178	CcSEcCtD
Flurbiprofen—Pain—Doxorubicin—lung cancer	2.43e-05	0.000175	CcSEcCtD
Flurbiprofen—Constipation—Doxorubicin—lung cancer	2.43e-05	0.000175	CcSEcCtD
Flurbiprofen—Hypersensitivity—Methotrexate—lung cancer	2.42e-05	0.000174	CcSEcCtD
Flurbiprofen—Asthenia—Methotrexate—lung cancer	2.35e-05	0.00017	CcSEcCtD
Flurbiprofen—Feeling abnormal—Doxorubicin—lung cancer	2.34e-05	0.000169	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Doxorubicin—lung cancer	2.32e-05	0.000167	CcSEcCtD
Flurbiprofen—Pruritus—Methotrexate—lung cancer	2.32e-05	0.000167	CcSEcCtD
Flurbiprofen—Urticaria—Doxorubicin—lung cancer	2.26e-05	0.000163	CcSEcCtD
Flurbiprofen—Abdominal pain—Doxorubicin—lung cancer	2.24e-05	0.000162	CcSEcCtD
Flurbiprofen—Body temperature increased—Doxorubicin—lung cancer	2.24e-05	0.000162	CcSEcCtD
Flurbiprofen—Diarrhoea—Methotrexate—lung cancer	2.24e-05	0.000162	CcSEcCtD
Flurbiprofen—Dizziness—Methotrexate—lung cancer	2.17e-05	0.000156	CcSEcCtD
Flurbiprofen—Hypersensitivity—Doxorubicin—lung cancer	2.09e-05	0.000151	CcSEcCtD
Flurbiprofen—Vomiting—Methotrexate—lung cancer	2.08e-05	0.00015	CcSEcCtD
Flurbiprofen—Rash—Methotrexate—lung cancer	2.07e-05	0.000149	CcSEcCtD
Flurbiprofen—Dermatitis—Methotrexate—lung cancer	2.07e-05	0.000149	CcSEcCtD
Flurbiprofen—Headache—Methotrexate—lung cancer	2.05e-05	0.000148	CcSEcCtD
Flurbiprofen—Asthenia—Doxorubicin—lung cancer	2.04e-05	0.000147	CcSEcCtD
Flurbiprofen—Pruritus—Doxorubicin—lung cancer	2.01e-05	0.000145	CcSEcCtD
Flurbiprofen—Nausea—Methotrexate—lung cancer	1.95e-05	0.00014	CcSEcCtD
Flurbiprofen—Diarrhoea—Doxorubicin—lung cancer	1.94e-05	0.00014	CcSEcCtD
Flurbiprofen—Dizziness—Doxorubicin—lung cancer	1.88e-05	0.000135	CcSEcCtD
Flurbiprofen—Vomiting—Doxorubicin—lung cancer	1.81e-05	0.00013	CcSEcCtD
Flurbiprofen—Rash—Doxorubicin—lung cancer	1.79e-05	0.000129	CcSEcCtD
Flurbiprofen—Dermatitis—Doxorubicin—lung cancer	1.79e-05	0.000129	CcSEcCtD
Flurbiprofen—Headache—Doxorubicin—lung cancer	1.78e-05	0.000128	CcSEcCtD
Flurbiprofen—Nausea—Doxorubicin—lung cancer	1.69e-05	0.000122	CcSEcCtD
Flurbiprofen—UGT1A1—Metabolism—CYP1A1—lung cancer	6.1e-06	6.21e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CYP1A1—lung cancer	6.1e-06	6.21e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EGF—lung cancer	6.1e-06	6.21e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CD—lung cancer	6.08e-06	6.19e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ERCC2—lung cancer	6.05e-06	6.16e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ERCC2—lung cancer	6.05e-06	6.16e-05	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PIK3CA—lung cancer	6.03e-06	6.14e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.02e-06	6.14e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTA4—lung cancer	6e-06	6.12e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—ALB—lung cancer	6e-06	6.11e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—HRAS—lung cancer	5.89e-06	6e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ALDOA—lung cancer	5.89e-06	6e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CG—lung cancer	5.88e-06	5.99e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.87e-06	5.98e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTA2—lung cancer	5.85e-06	5.96e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	5.85e-06	5.96e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.79e-06	5.9e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—CREBBP—lung cancer	5.72e-06	5.83e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NCOA3—lung cancer	5.71e-06	5.82e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTP1—lung cancer	5.71e-06	5.82e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTA1—lung cancer	5.64e-06	5.75e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FOXO3—lung cancer	5.64e-06	5.75e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.62e-06	5.72e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—POMC—lung cancer	5.6e-06	5.7e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	5.59e-06	5.7e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCC3—lung cancer	5.58e-06	5.69e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ADCY1—lung cancer	5.56e-06	5.66e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ABCG2—lung cancer	5.56e-06	5.66e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CAT—lung cancer	5.55e-06	5.66e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.52e-06	5.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP2E1—lung cancer	5.49e-06	5.6e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—HPGDS—lung cancer	5.45e-06	5.56e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ENO2—lung cancer	5.45e-06	5.56e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CREBBP—lung cancer	5.45e-06	5.55e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NQO1—lung cancer	5.43e-06	5.53e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CD—lung cancer	5.42e-06	5.53e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPP2R1B—lung cancer	5.42e-06	5.52e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKR1C1—lung cancer	5.41e-06	5.51e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ABCB1—lung cancer	5.4e-06	5.5e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.35e-06	5.45e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.32e-06	5.42e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—TYMS—lung cancer	5.3e-06	5.41e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CB—lung cancer	5.3e-06	5.4e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTT1—lung cancer	5.29e-06	5.39e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTGS2—lung cancer	5.25e-06	5.35e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—UGT1A1—lung cancer	5.25e-06	5.35e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTM1—lung cancer	5.24e-06	5.34e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—APOA1—lung cancer	5.23e-06	5.33e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—APOA1—lung cancer	5.23e-06	5.33e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP2A6—lung cancer	5.23e-06	5.33e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GCLC—lung cancer	5.23e-06	5.33e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.21e-06	5.31e-05	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—AKT1—lung cancer	5.2e-06	5.3e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CD—lung cancer	5.17e-06	5.27e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—ALB—lung cancer	5.1e-06	5.2e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GNG11—lung cancer	5.06e-06	5.16e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.03e-06	5.13e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.01e-06	5.11e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HES1—lung cancer	5e-06	5.09e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CYP1A1—lung cancer	4.97e-06	5.07e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ENO1—lung cancer	4.95e-06	5.05e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	4.95e-06	5.04e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.94e-06	5.03e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ERCC2—lung cancer	4.93e-06	5.02e-05	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AKT1—lung cancer	4.92e-06	5.02e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—STK11—lung cancer	4.9e-06	4.99e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—RAF1—lung cancer	4.84e-06	4.93e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALDOA—lung cancer	4.82e-06	4.91e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CG—lung cancer	4.78e-06	4.87e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CG—lung cancer	4.78e-06	4.87e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CB—lung cancer	4.73e-06	4.82e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NCOA3—lung cancer	4.68e-06	4.77e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ERCC2—lung cancer	4.67e-06	4.76e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.6e-06	4.68e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.6e-06	4.68e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTEN—lung cancer	4.58e-06	4.66e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ERBB3—lung cancer	4.57e-06	4.66e-05	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	4.57e-06	4.65e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ADCY1—lung cancer	4.55e-06	4.64e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCG2—lung cancer	4.55e-06	4.64e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—POMC—lung cancer	4.55e-06	4.63e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—POMC—lung cancer	4.55e-06	4.63e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTP1—lung cancer	4.53e-06	4.62e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CB—lung cancer	4.5e-06	4.59e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTGS2—lung cancer	4.46e-06	4.55e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ENO2—lung cancer	4.46e-06	4.55e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—HPGDS—lung cancer	4.46e-06	4.55e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP2E1—lung cancer	4.44e-06	4.53e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.43e-06	4.52e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CREBBP—lung cancer	4.43e-06	4.51e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CREBBP—lung cancer	4.43e-06	4.51e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CAT—lung cancer	4.41e-06	4.49e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NQO1—lung cancer	4.39e-06	4.48e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.38e-06	4.47e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TERT—lung cancer	4.38e-06	4.46e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.38e-06	4.46e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—EP300—lung cancer	4.37e-06	4.45e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IL2—lung cancer	4.34e-06	4.42e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTT1—lung cancer	4.33e-06	4.41e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.3e-06	4.38e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ABCB1—lung cancer	4.29e-06	4.37e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP2A6—lung cancer	4.28e-06	4.36e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GCLC—lung cancer	4.28e-06	4.36e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—APOA1—lung cancer	4.26e-06	4.35e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.26e-06	4.34e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.26e-06	4.34e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGFR1—lung cancer	4.25e-06	4.33e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—TYMS—lung cancer	4.21e-06	4.29e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CD—lung cancer	4.2e-06	4.28e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CD—lung cancer	4.2e-06	4.28e-05	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	4.19e-06	4.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HIF1A—lung cancer	4.19e-06	4.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTM1—lung cancer	4.16e-06	4.24e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—ALB—lung cancer	4.15e-06	4.22e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—ALB—lung cancer	4.15e-06	4.22e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.08e-06	4.16e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ENO1—lung cancer	4.06e-06	4.13e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APOA1—lung cancer	4.04e-06	4.12e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.04e-06	4.12e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.99e-06	4.06e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—STK11—lung cancer	3.96e-06	4.04e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP1A1—lung cancer	3.95e-06	4.02e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ERCC2—lung cancer	3.91e-06	3.99e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EP300—lung cancer	3.89e-06	3.97e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CG—lung cancer	3.89e-06	3.97e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTEN—lung cancer	3.89e-06	3.97e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—SRC—lung cancer	3.79e-06	3.86e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.72e-06	3.79e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—EP300—lung cancer	3.71e-06	3.78e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—POMC—lung cancer	3.71e-06	3.78e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KIT—lung cancer	3.69e-06	3.76e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APC—lung cancer	3.69e-06	3.76e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VEGFA—lung cancer	3.69e-06	3.76e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTP1—lung cancer	3.66e-06	3.73e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CB—lung cancer	3.66e-06	3.73e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CB—lung cancer	3.66e-06	3.73e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EGF—lung cancer	3.65e-06	3.72e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—NRAS—lung cancer	3.64e-06	3.71e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP2E1—lung cancer	3.64e-06	3.71e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS2—lung cancer	3.63e-06	3.7e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS2—lung cancer	3.63e-06	3.7e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CREBBP—lung cancer	3.61e-06	3.68e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NQO1—lung cancer	3.6e-06	3.67e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CAT—lung cancer	3.57e-06	3.63e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.55e-06	3.61e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.52e-06	3.59e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.49e-06	3.56e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—MAPK3—lung cancer	3.49e-06	3.56e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—BRAF—lung cancer	3.47e-06	3.54e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ABCB1—lung cancer	3.47e-06	3.54e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—IL6R—lung cancer	3.43e-06	3.49e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CD—lung cancer	3.42e-06	3.49e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CREBBP—lung cancer	3.42e-06	3.49e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—TYMS—lung cancer	3.41e-06	3.47e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—APOA1—lung cancer	3.39e-06	3.45e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—ALB—lung cancer	3.38e-06	3.44e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTM1—lung cancer	3.37e-06	3.43e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MAP2K1—lung cancer	3.27e-06	3.33e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CD—lung cancer	3.24e-06	3.31e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—STK11—lung cancer	3.24e-06	3.3e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.24e-06	3.3e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CA—lung cancer	3.23e-06	3.29e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP1A1—lung cancer	3.19e-06	3.25e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—ERCC2—lung cancer	3.17e-06	3.23e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTEN—lung cancer	3.16e-06	3.22e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTEN—lung cancer	3.16e-06	3.22e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—KRAS—lung cancer	3.14e-06	3.2e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CG—lung cancer	3.09e-06	3.15e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.04e-06	3.1e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—EP300—lung cancer	3.02e-06	3.07e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—EP300—lung cancer	3.02e-06	3.07e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTP1—lung cancer	3e-06	3.06e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CB—lung cancer	2.98e-06	3.04e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTGS2—lung cancer	2.96e-06	3.01e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—POMC—lung cancer	2.94e-06	3e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CAT—lung cancer	2.92e-06	2.97e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MDM2—lung cancer	2.91e-06	2.96e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.9e-06	2.96e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—RAF1—lung cancer	2.9e-06	2.95e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CA—lung cancer	2.88e-06	2.94e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CREBBP—lung cancer	2.87e-06	2.92e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ERBB2—lung cancer	2.87e-06	2.92e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ABCB1—lung cancer	2.84e-06	2.89e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MTOR—lung cancer	2.83e-06	2.88e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CB—lung cancer	2.83e-06	2.88e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CD4—lung cancer	2.82e-06	2.88e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—TYMS—lung cancer	2.79e-06	2.84e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—lung cancer	2.79e-06	2.84e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTM1—lung cancer	2.76e-06	2.81e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CA—lung cancer	2.75e-06	2.8e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—APOA1—lung cancer	2.74e-06	2.79e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CD—lung cancer	2.72e-06	2.77e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—ALB—lung cancer	2.68e-06	2.73e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—HRAS—lung cancer	2.67e-06	2.72e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKT1—lung cancer	2.64e-06	2.69e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.62e-06	2.67e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP1A1—lung cancer	2.61e-06	2.66e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ERCC2—lung cancer	2.59e-06	2.64e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTEN—lung cancer	2.58e-06	2.63e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CG—lung cancer	2.5e-06	2.55e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—EP300—lung cancer	2.46e-06	2.51e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN1A—lung cancer	2.45e-06	2.5e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PTEN—lung cancer	2.44e-06	2.49e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—POMC—lung cancer	2.38e-06	2.43e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CB—lung cancer	2.37e-06	2.41e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT1—lung cancer	2.35e-06	2.4e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EP300—lung cancer	2.33e-06	2.38e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CREBBP—lung cancer	2.32e-06	2.36e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—SRC—lung cancer	2.27e-06	2.31e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKT1—lung cancer	2.24e-06	2.29e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—APOA1—lung cancer	2.24e-06	2.28e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CA—lung cancer	2.23e-06	2.27e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CA—lung cancer	2.23e-06	2.27e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CD—lung cancer	2.2e-06	2.24e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—STAT3—lung cancer	2.19e-06	2.23e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NRAS—lung cancer	2.18e-06	2.22e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.15e-06	2.19e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MAPK3—lung cancer	2.09e-06	2.13e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CG—lung cancer	2.05e-06	2.09e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PTEN—lung cancer	2.05e-06	2.09e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MYC—lung cancer	2.03e-06	2.07e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EGFR—lung cancer	1.99e-06	2.02e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—EP300—lung cancer	1.95e-06	1.99e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—POMC—lung cancer	1.95e-06	1.99e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CB—lung cancer	1.92e-06	1.95e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS2—lung cancer	1.9e-06	1.93e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CREBBP—lung cancer	1.9e-06	1.93e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KRAS—lung cancer	1.88e-06	1.91e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKT1—lung cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKT1—lung cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CA—lung cancer	1.82e-06	1.85e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CD—lung cancer	1.8e-06	1.83e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ALB—lung cancer	1.78e-06	1.81e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CA—lung cancer	1.72e-06	1.76e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTEN—lung cancer	1.66e-06	1.69e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HRAS—lung cancer	1.6e-06	1.63e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—EP300—lung cancer	1.58e-06	1.61e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CB—lung cancer	1.57e-06	1.6e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS2—lung cancer	1.55e-06	1.58e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—IL6—lung cancer	1.53e-06	1.56e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKT1—lung cancer	1.49e-06	1.51e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CA—lung cancer	1.44e-06	1.47e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT1—lung cancer	1.41e-06	1.44e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTEN—lung cancer	1.36e-06	1.38e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—EP300—lung cancer	1.29e-06	1.32e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKT1—lung cancer	1.18e-06	1.2e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CA—lung cancer	1.17e-06	1.19e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CA—lung cancer	9.56e-07	9.74e-06	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKT1—lung cancer	9.54e-07	9.72e-06	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKT1—lung cancer	7.81e-07	7.96e-06	CbGpPWpGaD
